Kazia Therapeutics Limited
KZIA
$6.75
$0.172.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.46% | -21.23% | -157.48% | -151.13% | 35.64% |
| Total Depreciation and Amortization | -0.03% | 2.32% | -1.35% | -3.79% | -0.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 199.62% | 206.65% | 298.23% | 293.35% | -48.50% |
| Change in Net Operating Assets | -230.06% | -233.09% | 380.42% | 368.56% | -66.48% |
| Cash from Operations | -32.91% | -36.01% | 49.57% | 50.81% | 28.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 108.62% | 108.62% | -82.88% | -82.88% | -20.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 86.08% | 86.08% | -- |
| Cash from Financing | 104.91% | 109.69% | -82.93% | -83.35% | -19.51% |
| Foreign Exchange rate Adjustments | 190.76% | 192.72% | 34.72% | 31.37% | -528.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.80% | 185.75% | -320.98% | -315.51% | 44.00% |